Motion Lawnmn Tantum In

Motion Lawnmn Tantum In

MOTIONUS 20170234874A1 LAWNMN TANTUM IN ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2017/ 0234874 A1 Adams et al. (43 ) Pub. Date : Aug . 17 , 2017 ( 54 ) INTEGRATED VISUAL MORPHOLOGY AND Related U . S . Application Data CELL PROTEIN EXPRESSION USING (60 ) Provisional application No . 62 / 238 ,605 , filed on Oct . RESONANCE -LIGHT SCATTERING 7 , 2015 . (71 ) Applicant: Clearbridge BioPhotonics Pte Ltd ., Singapore (SG ) Publication Classification (51 ) Int . CI. (72 ) Inventors : Thomas H . Adams, Rancho Santa Fe, GOIN 33 / 569 ( 2006 .01 ) CA (US ) ; Stephen Roman Fait , GOIN 15 / 14 ( 2006 .01 ) Carlsbad , CA (US ) ; Eric Scott A61B 5 /00 ( 2006 .01 ) McCampbell , Carlsbad , CA (US ) ; GOIN 21 /552 ( 2006 .01 ) Michelle Brooke McCampbell , Rancho (52 ) U . S . Cl. Santa Fe, CA (US ); Edward Jablonski, CPC . GOIN 33 /56966 (2013 .01 ) ; GOIN 21/ 553 Escondido , CA (US ) ; Robert Earl ( 2013 .01 ) ; GOIN 15 / 1456 ( 2013 .01 ) ; A61B Klem , Rancho Santa Fe, CA (US ) 5 /0082 ( 2013 .01 ); G06T 7 / 0012 ( 2013 .01 ) ( 57 ) ABSTRACT (21 ) Appl . No. : 15 / 286 , 340 The invention relates to detecting cell biomarker signatures and integrated cell biomarker- morphological profiles by detecting resonance - light scattering of functionalized nano (22 ) Filed : Oct. 5 , 2016 particles. General Protocol for successive displacements of labelled nanoparticles ( free ) + 1st oligo Rev . compl. ds - hybridization relatively lower Tm ds- hybridization to 1st oligo relatively higher Tm next Ab -np Rev. compl. Add 3rd oligo to 3rd oligo .. Add 1st Ab - no to displace to cell Scan / image np -oligo 1st Ab -op cell cell cell First plurality of functionalized nanoparticle species comprises 1st Ab -np Then , add next Ab -np to interrogate next antigen (serially or in parallel) , repeat process n times . Patent Application Publication Aug. 17 , 2017 Sheet 1 of 25 US 2017 / 0234874 A1 edi **** *** * cell *** * ets * nextAb-np * 1stoligo itti (free) .. .. cell nextantigen(seriallyorinparallel), relativelyhigherTm Then,addnextAb-nptointerrogate Add3rdoligo times.processnrepeat ds-hybridization todisplace no-oligo Scan/image cell relativelylowerTm Add1stAb-np Fig.1-GeneralProtocolforsuccessivedisplacementsoflabellednanoparticles ds-hybridization tocell cell comprises1stAb-np 1stAb-np Firstpluralityoffunctionalized nanoparticlespecies Rev.compl Ab Rev.compl to1stoligo to3rdoligo Patent Application Publication Aug. 17 , 2017 Sheet 2 of 25 US 2017 / 0234874 A1 (free) *** * *. it relativelyhigherTm ds-hybridization, 919+* ware (free) inute "M * * * ** **** * * * relativelyhigherTm * oligo-B ds-hybridization, * *** ** oligo-A Fig.2-Alternativedisplacementembodiments OR relativelylowerTm ds-hybridization, Patent Application Publication Aug. 17 , 2017 Sheet 3 of 25 US 2017 /0234874 A1 T! (free) relativelyhigherTm ds-hybridization, *** * * ** *" Fig.3-Alternativedisplacementembodiments:displacingbridgingoligo Addoligo-D relativelylowerTm ds-hybridization, Patent Application Publication Aug. 17 , 2017 Sheet 4 of 25 US 2017 / 0234874 A1 **** * * * * * * * * * * * * * * SAV=streptavidin b=biotin SAV +SAV 1111111111111111111*1* 2)Wash(PBS COOH1)EDC/NHS Fig.4-Nanoparticlefunctionalizationdirectlylinked Biotin-NHS OR Maleimide-BiotinBiotin-Maleimide du S NH SH Hindistinctio I**!! !! ! ! !! ! ! Patent Application Publication Aug. 17 , 2017 Sheet 5 of 25 US 2017 /0234874 A1 +q Capunreacted SAVwithfreebiotin +biotin-oligo SAVou"SOMEDCNHS +amine-oligo +SAV Fig.5a-Nanoparticlefunctionalizationoligonucleotideoverlap OR 2)Wash(PBS) COOH1)EDC/NHSNHL 2)Wash(PBS COOH1)EDC/NHS du tot Patent Application Publication Aug . 17 , 2017 Sheet 6 of 25 US 2017 / 0234874 A1 W 5°)':3 53' 1111111111iiiiii*** +)du Fig.5b-Nanoparticlefunctionalizationoligonucleotideoverlap +Maleimideoligo Mar SH Patent Application Publication Aug. 17 , 2017 Sheet 7 of 25 US 2017 / 0234874 A1 OR . incinin w \5' w 3' (bridgingoligo) +AV 111* !!! ! ! 3:115 :11 :31 :1111 :111 ) Fig.6-Nanoparticlefunctionalizationoligonucleotidebridge +Maleimideoligo ???? SH Patent Application Publication Aug . 17 , 2017 Sheet 8 of 25 US 2017 /0234874 A1 wnios FIG.7 Patent Application Publication Aug . 17 , 2017 Sheet 9 of 25 US 2017 / 0234874 A1 . ' . ' . ' . ' . ' . ! ! . 50um FIG.8A Patent Application Publication Aug . 17, 2017 Sheet 10 of 25 US 2017 /0234874 A1 . : : 8 .', . FIG.8B Patent Application Publication Aug . 17, 2017 Sheet 11 of 25 US 2017 /0234874 A1 FIG.9 Patent Application Publication Aug . 17, 2017 Sheet 12 of 25 US 2017 /0234874 A1 FIG.10 Patent Application Publication Aug . 17, 2017 Sheet 13 of 25 US 2017 /0234874 A1 50um FIG.11 :: :: :: : :: : : : : : : : : : : : : : : : : : : :: : : : : : :: : : : : : : : : : : : : :: Patent Application Publication Aug . 17, 2017 Sheet 14 of 25 US 2017 /0234874 A1 Green Blue Yellow : 5um FIG.12 Patent Application Publication Aug . 17 , 2017 Sheet 15 of 25 US 2017 /0234874 A1 FIG.13 Patent Application Publication Aug . 17, 2017 Sheet 16 of 25 US 2017 /0234874 A1 . !', . ! . .! . ,'. .' . .' . 2 . .. .' ,' . ..'" Hrrrrrrrrr.: . .' .'" . .' . .',. .' . ..',. '. Di . ... !. :. .: . .'" . .1777 .. I . .' . : I . .' . 7 . 2017. .'. .: . ! . ! . ' :5 .' . ', . Green : .' ', . : . mintain . ', . ', . : . .' :. :: : "'. : . .: . : . 7 . 199 . :. 11:. : . Blue Yellow . ': . '. ' . ' . :::: : . ' . ' . ' . ' . .. : . : . : . ! ' . LLLLLLLLLLLLLLLL.!:' . .I.',. .. .! . : . 13: . : . .'" . : .' . .' . .' . .' : . : .' . .' . : . IIIIIIIIIIIIIIIIIIIIII.'IIIIIIIIIIIIIIIIII.", . : . ... : . : . "'. : . Orange . .' . ! '.,', . .' . ,'. .' . .: .' . : : . IIIIIIIIIII.:' . - . 5um . ',iiii. * . ..,' ' .!' . ., . ' . .: FIG.14 . :' : . i.iii : . 1:32 . .. - : ' . ' ' ' ' ' ' ' ' ' ' ' : : : . Patent Application Publication Aug . 17, 2017 Sheet 17 of 25 US 2017 /0234874 A1 FIG.15 Patent Application Publication Aug . 17, 2017 Sheet 18 of 25 US 2017 /0234874 A1 FIG.16 Patent Application Publication Aug . 17, 2017 Sheet 19 of 25 US 2017 /0234874 A1 FIG.17 Patent Application Publication Aug . 17, 2017 Sheet 20 of 25 US 2017 /0234874 A1 FIG.18 Patent Application Publication Aug . 17, 2017 Sheet 21 of 25 US 2017 /0234874 A1 FIG.19B Auanti-CD3(yellow)andAgCD4 particlesfieldnothe-lymphocytesin (blue)particlesbindtothefour bindtoneutrophils . : : : : : : : : . : . .. .. : .- :',1 .. 7 . .! . .IIIIII', .'. : : : YYYYYYYYYYYYY . : . .. W . 1 . : FIG.190 FIG.19A . .: . .': .. : .. ." . .... .: . u . .. .. IIIIIII : . 77777777777777777777777777777 . : 1111111111 : : : : : : : : . : : . 1 . 1 . 1 . 1 !. 1 . 23: . : . 23:31 .. .! : . - . iiiiiiiiiiiM . : 7 .. 2 . : < . : . : - . FIG.19D .'viri. !'. ' . .' . .. : . '. ) . .' . .. I V iscsiiiiiiiiiiiiiiiiiiiiiiii . Patent Application Publication Aug . 17, 2017 Sheet 22 of 25 US 2017 /0234874 A1 CD4+,CD3 CellType t CD3-,CD4 Blue/darker THelperCell Yellow/lighter CD3,CD4 Neutrophil particles particles TCell : : :: : : . .' : : : : .. '. : . :-: . : : : : :: . : . :: :: . .' : :: : :: : : : :: :: : :: : :: : . .' : : : : : : : . .' : : : : :: ',. .' : : :: . .' : : : . .' . .' : . .' . * .' . * . 1 . Darkfield .' .' 13 : : : : . : .' : : :: FIG.197 : : : : : : : : : : : :: : . : . : . : . : . : . : . : . : FIG.19H FIG.191 . Brightfield FIG.191 FIG.19EFIG.19E FIG.19G Patent Application Publication Aug . 17 , 2017 Sheet 23 of 25 US 2017 /0234874 A1 to13outof14anti-CD3(yellow)bindAu noparticleslymphocytesinthefield- neutrophilstobind FIG.20B . LLLLLLLLLLLLL 3 . : 1 . IIII , , . 15 : FIG,200 : . : 1 9.. FIG.20A 20DFIG. E Patent Application Publication Aug . 17, 2017 Sheet 24 of 25 US 2017 /0234874 A1 FIG.21B : FIG.21AFIG.21A . ( . Patent Application Publication Aug . 17, 2017 Sheet 25 of 25 US 2017 /0234874 A1 . .: . : Green/darker . : . Yellow/lighter FIG.22 US 2017 /0234874 A1 Aug . 17 , 2017 INTEGRATED VISUAL MORPHOLOGY AND using the resonant light scattering properties of the particles CELL PROTEIN EXPRESSION USING are : ( a ) the nanoparticles can be detected and imaged at RESONANCE -LIGHT SCATTERING magnifications as low as 10x using a simple illuminator, such as a white light illuminator , with dark field illumina RELATED APPLICATIONS tion , ( b ) the nanoparticles provide a non -bleaching signal, ( c ) the color of scattered light can be changed by changing [0001 ] This application claims the benefit of U . S . Provi nanoparticle size and / or composition for multicolor multi sional Application Ser . No . 62 /238 ,605 , filed on Oct . 7 , plexing , ( d ) the nanoparticles can be conjugated with bio 2015 , the entire contents of which is hereby incorporated be marker - binding moieties for specific analyte detection to reference in its entirety . create functionalized nanoparticles, ( e ) biological samples contacted with the functionalized nanoparticles are archiv FIELD able , and ( f ) the functionalized nanoparticles exhibit a [0002 ] The presently disclosed subject matter relates to greater range of linearity of detection when present on a cell compositions and methods for integrated visualmorphology because the particles do not self- quench . In some embodi and cell protein expression analysis . ments , the methods of this invention are useful in obtaining images of cell - functionalized nanoparticle complexes under INTRODUCTION AND SUMMARY OF THE ambient conditions which do not require use of a darkroom , INVENTION in contrast to fluorescent labeling systems. In some embodi [0003 ] Cellular analysis is an important tool in histopa ments , the samples may be viewed on a microscope in a thology to aid in diagnosing

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    67 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us